At Dana-Farber/Brigham and Women's Cancer Center, your health and safety, along with the health and safety of our staff, are our top priorities. As our cancer specialists continue to learn more about the rapidly evolving COVID-19 (2019 Novel Coronavirus) pandemic, we want to keep our new and existing cancer patients informed. Visit our COVID-19 FAQ: For Cancer Patients for answers to some of the common questions cancer patients and caregivers are asking about COVID-19.
Dr. Daphne Haas-Kogan, chair of the Department of Radiation Oncology at Dana-Farber/Brigham and Women’s Cancer Center, shares the many safety measures implemented to ensure hundreds of cancer patients continue to receive cutting-edge, patient-centered cancer care during COVID-19.
About Surgical Oncology
At the Division of Surgical Oncology at Brigham and Women’s Hospital (BWH), you will be treated by highly trained, specialized surgical oncologists with years of experience in surgery and cancer care. All of our surgical oncologists are board certified and faculty members at Harvard Medical School. We train the next generation of surgical oncologists through the Dana-Farber/Partners Cancer Care Surgical Oncology Fellowship.
Our surgeons are also active physician researchers; Dr. Bertagnolli directs the BWH Surgical Oncology Lab and also serves as Group Chair for The Alliance for Clinical Trials in Oncology. The Alliance is an NCI-funded cancer cooperative group formed in 2011 by the merger of the American College of Surgeons Oncology Group, the Cancer and Leukemia Group B, and the North Central Cancer Treatment Group.